Skip to main content
. 2023 May 8;13(5):800. doi: 10.3390/biom13050800

Table 3.

Platelet 5-HT concentration and platelet MAO-B activity in patients with different asthma phenotypes.

Asthma Phenotypes Platelet 5-HT Concentration
(nmol/mg Protein)
Platelet MAO-B Activity
(nmol/mg of Protein Per Hour)
T2-high (N = 94)
T2-low (N = 26)
0.79 (0.62; 1.09) p = 0.73;
U = 1168.00
FC = 0.95
42.98 (35.30; 58.48) p = 0.60;
U = 1140.00
FC = 0.96
0.91 (0.60; 1.09) 44.27 (31.81; 58.98)
Non-allergic (N = 42)
Allergic (N = 78)
0.85 (0.62; 1.18) p = 0.77;
U = 1585.00
FC = 1.02
37.79 (31.67; 57.17) p = 0.047;
U = 1278.00
FC = 1.13
0.77 (0.62; 1.08) 44.87 (36.73; 58.60)
Non-eosinophilic (N = 73)
Eosinophilic (N = 47)
0.81 (0.62; 1.05) p = 0.39;
U = 1554.00
FC = 1.09
41.91 (33.63; 59.14) p = 0.57;
U = 1609.00
FC = 1.03
0.86 (0.64; 1.19) 44.61 (35.32; 57.49)
Non-AERD (N = 111)
AERD (N = 9)
0.81 (0.62; 1.08) p = 0.42;
U = 413.50
FC = 1.05
43.15 (34.07; 58.60) p = 0.71;
U = 457.00
FC = 0.95
0.82 (0.69; 1.31) 36.50 (33.93; 57.21)

Platelet 5-HT concentration and MAO-B activity are presented as median with 25th (Q1) and 75th (Q3) percentiles and compared in patients with different asthma phenotypes using the Mann-Whitney test; AERD = aspirin-exacerbated respiratory disease. FC = fold change.